The U.S. Food and Drug Administration (FDA) has approved use of the five-day, once-daily regimen of LEVAQUIN(R) (levofloxacin) 750 mg I.V. and oral, for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP). [click link for full article]
From: www.medicalnewstoday.com
R) Short Course Therapy For Treatment Of Complicated Urinary Tract Infections And Acute ...
Posted by Ruslan Abuzant at 3:21 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment